These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17606691)

  • 21. Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice.
    Smee DF; Sidwell RW; Huffman JH; Huggins JW; Kende M; Verbiscar AJ
    Chemotherapy; 1996; 42(4):286-93. PubMed ID: 8804797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug.
    Tanaka T; Kamiyama T; Daikoku T; Takahashi K; Nomura N; Kurokawa M; Shiraki K
    Acta Virol; 2017; 61(1):48-55. PubMed ID: 28105854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of T-1106 in a hamster model of yellow Fever virus infection.
    Julander JG; Furuta Y; Shafer K; Sidwell RW
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine.
    Smee DF; Morris JL; Barnard DL; Van Aerschot A
    Antiviral Res; 1992 Jun; 18(2):151-62. PubMed ID: 1365816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo activities of T-705 and oseltamivir against influenza virus.
    Takahashi K; Furuta Y; Fukuda Y; Kuno M; Kamiyama T; Kozaki K; Nomura N; Egawa H; Minami S; Shiraki K
    Antivir Chem Chemother; 2003 Sep; 14(5):235-41. PubMed ID: 14694986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A biotechnological product and its potential as a new immunomodulator for treatment of animal phlebovirus infection: Punta Toro virus.
    Durán N; Gowen BB; Costa FT; Justo GZ; Brocchi M; Nunes OS; Nunes IS
    Antiviral Res; 2009 Aug; 83(2):143-7. PubMed ID: 19393266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genistein, a general kinase inhibitor, as a potential antiviral for arenaviral hemorrhagic fever as described in the Pirital virus-Syrian golden hamster model.
    Vela EM; Knostman KA; Mott JM; Warren RL; Garver JN; Vela LJ; Stammen RL
    Antiviral Res; 2010 Sep; 87(3):318-28. PubMed ID: 20600333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride.
    Gabrielsen B; Phelan MJ; Barthel-Rosa L; See C; Huggins JW; Kefauver DF; Monath TP; Ussery MA; Chmurny GN; Schubert EM
    J Med Chem; 1992 Aug; 35(17):3231-8. PubMed ID: 1507208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease.
    Westover JB; Bailey KW; Wasson SR; Boardman KM; Lustig KH; Amberg SM; Gowen BB
    Antiviral Res; 2024 Sep; 229():105952. PubMed ID: 38945484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model.
    Pascua PNQ; Marathe BM; Vogel P; Webby RJ; Govorkova EA
    J Antimicrob Chemother; 2019 May; 74(5):1333-1341. PubMed ID: 30715325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo activities of anti-influenza virus compound T-705.
    Furuta Y; Takahashi K; Fukuda Y; Kuno M; Kamiyama T; Kozaki K; Nomura N; Egawa H; Minami S; Watanabe Y; Narita H; Shiraki K
    Antimicrob Agents Chemother; 2002 Apr; 46(4):977-81. PubMed ID: 11897578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.
    Gowen BB; Sefing EJ; Westover JB; Smee DF; Hagloch J; Furuta Y; Hall JO
    Antiviral Res; 2015 Sep; 121():132-7. PubMed ID: 26186980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections.
    Sidwell RW; Huffman JH; Barnard DL; Smee DF; Warren RP; Chirigos MA; Kende M; Huggins J
    Antiviral Res; 1994 Oct; 25(2):105-22. PubMed ID: 7847873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.
    Furuta Y; Takahashi K; Shiraki K; Sakamoto K; Smee DF; Barnard DL; Gowen BB; Julander JG; Morrey JD
    Antiviral Res; 2009 Jun; 82(3):95-102. PubMed ID: 19428599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S
    J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.
    Gowen BB; Westover JB; Sefing EJ; Van Wettere AJ; Bailey KW; Wandersee L; Komeno T; Furuta Y
    Antiviral Res; 2017 Sep; 145():131-135. PubMed ID: 28780425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
    Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.
    Gowen BB; Juelich TL; Sefing EJ; Brasel T; Smith JK; Zhang L; Tigabu B; Hill TE; Yun T; Pietzsch C; Furuta Y; Freiberg AN
    PLoS Negl Trop Dis; 2013; 7(12):e2614. PubMed ID: 24386500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current drug discovery strategies against arenavirus infections.
    Pasquato A; Burri DJ; Kunz S
    Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1297-309. PubMed ID: 23241187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.